Aker Biomarine (Norway) Today
| AKBM Stock | 60.00 0.10 0.17% |
Performance2 of 100
| Odds Of DistressLess than 30
|
Aker Biomarine is selling for 60.00 as of the 30th of November 2024. This is a 0.17 percent up since the beginning of the trading day. The stock's lowest day price was 59.4. Aker Biomarine has about a 30 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Aker Biomarine AS are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of October 2024 and ending today, the 30th of November 2024. Click here to learn more.
Moving against Aker Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aker Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aker Biomarine's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aker Biomarine or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Packaged Foods, Consumer Defensive (View all Sectors) |
Aker Biomarine AS (AKBM) is traded on Oslo Stock Exchange in Norway and employs 429 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aker Biomarine's market, we take the total number of its shares issued and multiply it by Aker Biomarine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aker Biomarine AS operates under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 87.65 M outstanding shares.
Aker Biomarine AS has accumulated about 9.15 M in cash with 729 K of positive cash flow from operations.
Check Aker Biomarine Probability Of Bankruptcy
Ownership AllocationAker Biomarine holds a total of 87.65 Million outstanding shares. Aker Biomarine AS shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.01 percent of Aker Biomarine AS outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aker Ownership Details
Aker Biomarine AS Risk Profiles
Although Aker Biomarine's alpha and beta are two of the key measurements used to evaluate Aker Biomarine's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.23 | |||
| Semi Deviation | 2.52 | |||
| Standard Deviation | 2.85 | |||
| Variance | 8.11 |
Aker Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aker Biomarine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Aker Biomarine Corporate Management
Elected by the shareholders, the Aker Biomarine's board of directors comprises two types of representatives: Aker Biomarine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aker. The board's role is to monitor Aker Biomarine's management team and ensure that shareholders' interests are well served. Aker Biomarine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aker Biomarine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Trond Smedsrud | Ex Investments | Profile | |
| Tone Lorentzen | Ex Chain | Profile | |
| Lise Wiger | Financial Controller | Profile | |
| Sigve Nordrum | Ex Nutrition | Profile | |
| Katrine Klaveness | Chief Officer | Profile | |
| Seth French | Chief Inc | Profile | |
| Matts Johansen | Chief Officer | Profile |
Other Information on Investing in Aker Stock
Aker Biomarine financial ratios help investors to determine whether Aker Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aker with respect to the benefits of owning Aker Biomarine security.